18 trials changed in the last 30 days: 3 stopped, 5 with notable changes, 10 with minor changes only.
Trial terminated
Also in this update: Primary endpoint(s) modified; Results posted: Oct 14, 2026
Eidos Therapeutics, a BridgeBio companyPhase 2 NCT03536767 Registry history of NCT03536767 on ClinicalTrials.gov (opens the registry)
Trial status changed: Recruiting → Withdrawn
Beijing Boren HospitalEarly Phase 1 NCT07626476 Registry history of NCT07626476 on ClinicalTrials.gov (opens the registry)
Trial status changed: Recruiting → Withdrawn
Beijing Boren HospitalNot applicable NCT06983951 Registry history of NCT06983951 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Sep 2026 to Sep 2027
Memorial Sloan Kettering Cancer CenterPhase 1 NCT02909036 Registry history of NCT02909036 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Nov 30, 2026 to Nov 30, 2029
Also in this update: Study completion pushed from Nov 30, 2026 to Nov 30, 2031
Mayo ClinicPhase 2 NCT05898646 Registry history of NCT05898646 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Jan 30, 2029 to Sep 23, 2029
Also in this update: Recruitment opened; Start date changed from estimate of Dec 30, 2026 to Sep 23, 2026
University Hospital, MontpellierNot applicable NCT07494942 Registry history of NCT07494942 on ClinicalTrials.gov (opens the registry)
Primary endpoint(s) modified
Also in this update: Trial sites expanded: 35 → 38 locations; Study completion pushed from Aug 15, 2028 to Feb 9, 2030; and 1 more change in the last 30 days
Novo Nordisk A/SPhase 2 NCT06260709 Registry history of NCT06260709 on ClinicalTrials.gov (opens the registry)
Primary endpoint(s) modified
Also in this update: Recruitment opened; Trial sites expanded: 0 → 10 locations
Medical University of ViennaNot applicable NCT06075823 Registry history of NCT06075823 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Feb 28, 2028 to Apr 15, 2028
Also in this update: Study completion pushed from Mar 28, 2028 to May 15, 2028
BayerNot specified NCT07557147 Registry history of NCT07557147 on ClinicalTrials.gov (opens the registry)
Completed without a posted recruiting period
Also in this update: Trial sites expanded: 0 → 3 locations; Interventions modified
Universidad de BurgosNot applicable NCT07343999 Registry history of NCT07343999 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Oct 10, 2026 to Nov 10, 2026
University of MinnesotaNot applicable NCT07583823 Registry history of NCT07583823 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Dec 18, 2026 to May 15, 2027
Mayo ClinicPhase 2 NCT07285044 Registry history of NCT07285044 on ClinicalTrials.gov (opens the registry)
Enrollment increased: 240 → 276 participants
And 2 more changes in the last 30 days
Janssen Research & Development, LLCPhase 1 NCT06768489 Registry history of NCT06768489 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 56 → 61 locations
Alnylam PharmaceuticalsPhase 3 NCT07223203 Registry history of NCT07223203 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 24 → 27 locations
Alnylam PharmaceuticalsNot specified NCT07358078 Registry history of NCT07358078 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 1 → 17 locations
Also in this update: Study completion moved earlier from Jul 3, 2028 to Apr 30, 2028
BayerNot specified NCT07235462 Registry history of NCT07235462 on ClinicalTrials.gov (opens the registry)
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCSNot applicable NCT05929209 Registry history of NCT05929209 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
Fundación Pública Andaluza para la gestión de la Investigación en SevillaNot specified NCT05176548 Registry history of NCT05176548 on ClinicalTrials.gov (opens the registry)
Changed
Registry verification sweep
Changed
| First posted | Trial | Sponsor | Phase |
|---|---|---|---|
| 2026-10-14 | NCT07874334 Phase 1a/b Study of GPRC5D CART Therapy in Relapsed/Refractory Multiple Myeloma and… | Hadassah Medical Organization new | Phase 1 |
| 2026-08-25 | NCT07784712 Right Ventricular Septal Biopsy to Detect Cardiac Amyloidosis | Geisinger Clinic new | |
| 2026-08-14 | NCT07765524 A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety… | Shenzhen Fosun Kairos Biotechnology Co., Ltd. new | Phase 1/2 |
| 2026-08-07 | NCT07752732 Non-Interventional Study on the Prevalence of Cardiac Amyloidosis in Patients With… | University Hospital Tuebingen new | |
| 2026-07-23 | NCT07721350 Prospective Evaluation of Subcutaneous Administration of Daratumumab by the FreedomEDGE®… | Hospices Civils de Lyon new |
| Early Phase 1 | 3 | |
| Phase 1 | 12 | |
| Phase 1/2 | 13 | |
| Phase 2 | 41 | |
| Phase 3 | 25 | |
| Phase 4 | 9 |
Alnylam Pharmaceuticals (9) · AstraZeneca (8) · Fondazione IRCCS Policlinico San Matteo di Pavia (7) · Mayo Clinic (7) · Alexion Pharmaceuticals, Inc. (6) · Peking Union Medical College Hospital (6) · Brigham and Women's Hospital (5) · University of Texas Southwestern Medical Center (5) · Bayer (4) · Eidos Therapeutics, a BridgeBio company (4)